Europe Manufacturing Execution System (MES) In Life Sciences Market Forecast to 2028–COVID-19 Impact and Regional Analysis– by Offering (Software and Services), Deployment (On-Premises and Cloud), Organization Size (SMEs and Large Enterprises), and Application (Pharmaceutical, Biotechnology, and Medical Devices)

BMIRE00028413 | Pages: 145 | Technology, Media and Telecommunications | May 2023 | Type: Regional | Status: Published

The Europe manufacturing execution system in life sciences market is expected to grow from US$ 987.17 million in 2023 to US$ 3,124.83 million by 2033 It is estimated to grow at a CAGR of 12.2% from 2023 to 2033.   

Requirement of Accurate Real-Time Data in Production Management Process Fuels Europe Manufacturing Execution System (MES) In Life Sciences Market

Pharmaceutical and medical device manufacturers face various challenges in a drastically changing landscape. Protectionist trade policies are creating supply chain challenges while increased state interventions are promoting regionalization. High inflation across several countries is increasing labor, raw materials, and transportation costs. The pharma industry is also facing talent shortages linked to broader labor market trends, including the 20% increase in demand for science, technology, engineering, and mathematics (STEM) related roles across the life sciences industry. The product landscape is also changing rapidly, with new modalities such as cell and gene therapy (CGT) and mRNA vaccine technology witnessing a high percent rise in the drug development pipeline. Despite being renowned for holding high inventory levels and long-standing dual-sourcing policies, the changing landscape has led pharmaceutical and medical device manufacturers to optimize their business processes, including adopting MES. Previously used paper-based systems are becoming obsolete as a larger emphasis is being laid upon gathering real-time data for improving process flow and reducing operational costs. MES can help manufacturers to function with a lower workforce, gather accurate real-time data from the production process, increase process efficiency and flexibility, safeguard regulatory expectations, and digitize the manufacturing process.

For instance, in September 2020, Korber and Walvax Biotechnology announced that it had signed an agreement to implement Werum PAS-X MES, the MES for pharma, biotech, and cell & gene therapy manufacturing, at its Yuxi plant for vaccine production. As per Korber, PAS-X MES allows the user to manage, visualize and analyze data fast, comprehensively, and in real time. Because of all the above advantages of using MES, various market players are adopting the system.

Europe Manufacturing Execution System (MES) In Life Sciences Market Overview

The Europe MES in life sciences market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Europe houses a few of the major medical device manufacturers, and the medical device industry in the region has experienced several cases of MES deployment in the past few years. As medical device companies are embracing digitalization in areas ranging from factory floor automation to back-office administration providing solutions to enhance efficiency in all departments. In May 2018, B Braun, one of the major medical device manufacturers headquartered in Europe, adopted the MES technology in its Melsungen facility. This deployment enabled B. Braun to adopt paperless digital manufacturing processes, thereby improving flexibility, agility, operational effectiveness, and product quality while cutting costs. Later, the company successfully updated its existing PAS-X system from PAS-X V2 to PAS-X V3 in plant A, headquartered in Melsungen. With MES, medical device companies can automatically control their manufacturing environment and easily manage regulatory inspections, alongside keeping up with the changing FDA and EU MRD requirements in a long run. AstraZeneca, Fareva, Ipsen, and Sanofi S.A. are a few of the pharmaceutical companies headquartered in Europe, which have implemented the XFP MES Suite offered by Elan, which is a part of Siemens. This suite provides production visibility and control throughout the enterprise by optimizing the entire production cycle, from raw material delivery to end product shipment, in compliance with 21CFR part 11 and ISA 88/95.

Europe Manufacturing Execution System (MES) In Life Sciences Market Revenue and Forecast to 2033 (US$ Million)

Europe Manufacturing Execution System (MES) In Life Sciences Market Revenue and Forecast to 2033 (US$ Million)

Get more information on this report :

Europe Manufacturing Execution System (MES) In Life Sciences Market Segmentation

The Europe manufacturing execution system in life sciences market is segmented into offering, deployment, organization size, application, and country.

Based on offering, the Europe manufacturing execution system in life sciences market is segmented into software and services. The services segment held a larger share of the Europe manufacturing execution system in life sciences market in 2023.

Based on deployment, the Europe manufacturing execution system in life sciences market is segmented into on-premises and cloud. The cloud segment held a larger share of the Europe manufacturing execution system in life sciences market in 2023.

Based on organization size, the Europe manufacturing execution system in life sciences market is segmented into SMEs and large enterprises. The large enterprises segment held the largest share of the Europe manufacturing execution system in life sciences market in 2023.

Based on application, the Europe manufacturing execution system in life sciences market is segmented into pharmaceutical, biotechnology, and medical devices. The medical devices segment held the largest share of the Europe manufacturing execution system in life sciences market in 2023.

Based on country, the Europe manufacturing execution system in life sciences market is segmented into Germany, France, Italy, the UK, Spain, and the Rest of Europe. Germany dominated the share of the Europe manufacturing execution system in life sciences market in 2023.   

ATS Global B.V.; Emerson Electric Co; Korber AG; LZ Lifescience Limited; Rockwell Automation Inc; Schneider Electric SE; and Siemens AG are the leading companies operating in the Europe manufacturing execution system in life sciences market.

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Europe Manufacturing Execution System in Life Sciences Market – By Offering

1.3.2        Europe Manufacturing Execution System in Life Sciences Market – By Deployment

1.3.3        Europe Manufacturing Execution System in Life Sciences Market – By Organization Size

1.3.4        Europe Manufacturing Execution System in Life Sciences Market – By Application

1.3.5        Europe Manufacturing Execution System in Life Sciences Market – By Country

2.           Europe Manufacturing Execution System in Life Sciences Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Manufacturing Execution System in Life Sciences Market – Market Landscape

4.1         Overview

4.2         Europe PEST Analysis

4.3         Ecosystem Analysis

4.4         Expert Opinion

5.           Europe Manufacturing Execution System in Life Sciences Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Need for Compliance with Regulatory Framework

5.1.2        Requirement of Accurate Real-Time Data in Production Management Process

5.2         Market Restraints

5.2.1        High Cost and Lack of Flexibility

5.3         Market Opportunities

5.3.1        Rising Application in Cell and Gene Therapy Sector

5.4         Future Trends

5.4.1        Shift from Legacy to Modern MES

5.4.2        Rise in Adoption of Pharma 4.0

5.5         Impact Analysis of Drivers and Restraints

6.           Manufacturing Execution System in Life Sciences Market – Europe Analysis

6.1         Europe Manufacturing Execution System in Life Sciences Market Overview

6.2         Europe Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)

7.           Europe Manufacturing Execution System in Life Sciences Market Analysis – By Offering

7.1         Overview

7.2         Europe Manufacturing Execution System in Life Sciences Market, By Offering (2022 and 2033)

7.3         Software

7.3.1        Overview

7.3.2        Software: Europe Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)

7.4         Services

7.4.1        Overview

7.4.2        Services: Europe Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)

8.           Europe Manufacturing Execution System in Life Sciences Market Analysis – By Deployment

8.1         Overview

8.2         Europe Manufacturing Execution System in Life Sciences Market, By Deployment (2022 and 2033)

8.3         On-Premises

8.3.1        Overview

8.3.2        On-Premises: Europe Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)

8.4         Cloud

8.4.1        Overview

8.4.2        Cloud: Europe Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)

9.           Europe Manufacturing Execution System in Life Sciences Market Analysis – By Organization Size

9.1         Overview

9.2         Europe Manufacturing Execution System in Life Sciences Market, By Organization Size (2022 and 2033)

9.3         SMEs

9.3.1        Overview

9.3.2        SMEs: Europe Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)

9.4         Large Enterprises

9.4.1        Overview

9.4.2        Large Enterprises: Europe Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)

10.        Europe Manufacturing Execution System in Life Sciences Market Analysis – By Application

10.1      Overview

10.2      Europe Manufacturing Execution System in Life Sciences Market, By Application (2022 and 2033)

10.3      Pharmaceutical

10.3.1     Overview

10.3.2     Pharmaceutical: Europe Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)

10.4      Biotechnology

10.4.1     Overview

10.4.2     Biotechnology: Europe Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)

10.5      Medical Devices

10.5.1     Overview

10.5.2     Medical Devices: Europe Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)

11.        Europe Manufacturing Execution System in Life Sciences Market Analysis – By Country

11.1      Overview

11.1.1     Europe Manufacturing Execution System in Life Sciences Market, by Country, 2022 & 2033 (%)

11.1.1.1       Germany: Europe Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)

11.1.1.1.1       Overview

11.1.1.1.2       Germany: Europe Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)

11.1.1.1.3       Germany: Europe Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)

11.1.1.1.4       Germany: Europe Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)

11.1.1.1.5       Germany: Europe Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)

11.1.1.1.6       Germany: Europe Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)

11.1.1.2       France: Europe Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)

11.1.1.2.1       Overview

11.1.1.2.2       France: Europe Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)

11.1.1.2.3       France: Europe Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)

11.1.1.2.4       France: Europe Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)

11.1.1.2.5       France: Europe Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)

11.1.1.2.6       France: Europe Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)

11.1.1.3       Italy: Europe Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)

11.1.1.3.1       Overview

11.1.1.3.2       Italy: Europe Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)

11.1.1.3.3       Italy: Europe Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)

11.1.1.3.4       Italy: Europe Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)

11.1.1.3.5       Italy: Europe Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)

11.1.1.3.6       Italy: Europe Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)

11.1.1.4       UK: Europe Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)

11.1.1.4.1       Overview

11.1.1.4.2       UK: Europe Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)

11.1.1.4.3       UK: Europe Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)

11.1.1.4.4       UK: Europe Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)

11.1.1.4.5       UK: Europe Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)

11.1.1.4.6       UK: Europe Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)

11.1.1.5       Spain: Europe Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)

11.1.1.5.1       Overview

11.1.1.5.2       Spain: Europe Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)

11.1.1.5.3       Spain: Europe Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)

11.1.1.5.4       Spain: Europe Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)

11.1.1.5.5       Spain: Europe Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)

11.1.1.5.6       Spain: Europe Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)

11.1.1.6       Rest of Europe: Europe Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)

11.1.1.6.1       Overview

11.1.1.6.2       Rest of Europe: Europe Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)

11.1.1.6.3       Rest of Europe: Europe Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)

11.1.1.6.4       Rest of Europe: Europe Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)

11.1.1.6.5       Rest of Europe: Europe Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)

11.1.1.6.6       Rest of Europe: Europe Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)

12.        Industry Landscape

12.1      Overview

12.2      Market Initiatives, Expansions, and Strategic Developments

12.3      New Product/Feature Development

12.4      Mergers and Acquisitions

12.5      Agreements, Collaborations, and Joint Ventures

13.        Company Profiles

13.1      ATS Global B.V.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Emerson Electric Co

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      LZ Lifescience Limited

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Korber AG

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Rockwell Automation Inc

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Schneider Electric SE

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Siemens AG

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Word Index

 

 

LIST OF TABLES

Table 1.             Europe Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2023 (US$ Million)

Table 2.             Germany: Europe Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)

Table 3.             Germany: Europe Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)

Table 4.             Germany: Europe Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)

Table 5.             Germany: Europe Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)

Table 6.             France: Europe Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)

Table 7.             France: Europe Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)

Table 8.             France: Europe Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)

Table 9.             France: Europe Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)

Table 10.          Italy: Europe Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)

Table 11.          Italy: Europe Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)

Table 12.          Italy: Europe Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)

Table 13.          Italy: Europe Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)

Table 14.          UK: Europe Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)

Table 15.          UK: Europe Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)

Table 16.          UK: Europe Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)

Table 17.          UK: Europe Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)

Table 18.          Spain: Europe Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)

Table 19.          Spain: Europe Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)

Table 20.          Spain: Europe Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)

Table 21.          Spain: Europe Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)

Table 22.          Rest of Europe: Europe Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)

Table 23.          Rest of Europe: Europe Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)

Table 24.          Rest of Europe: Europe Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)

Table 25.          Rest of Europe: Europe Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)

Table 26.          List of Abbreviation

 

 

LIST OF FIGURES

Figure 1.           Europe Manufacturing Execution System in Life Sciences Market Segmentation

Figure 2.           Europe Manufacturing Execution System in Life Sciences Market Segmentation, By Country

Figure 3.           Europe Manufacturing Execution System in Life Sciences Market Overview

Figure 4.           Services Held Largest Share Of Offering Segment In Europe Manufacturing Execution System in Life Sciences Market

Figure 5.           Germany Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           Europe: PEST Analysis

Figure 7.           Expert Opinion

Figure 8.           Europe Manufacturing Execution System in Life Sciences Market: Impact Analysis of Drivers and Restraints

Figure 9.           Europe Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)

Figure 10.        Europe Manufacturing Execution System in Life Sciences Market Revenue Share, By Offering (2022 and 2033)

Figure 11.        Software: Europe Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)

Figure 12.        Services: Europe Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)

Figure 13.        Europe Manufacturing Execution System in Life Sciences Market Revenue Share, By Deployment (2022 and 2033)

Figure 14.        On-Premises: Europe Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)

Figure 15.        Cloud: Europe Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)

Figure 16.        Europe Manufacturing Execution System in Life Sciences Market Revenue Share, By Organization Size (2022 and 2033)

Figure 17.        SMEs: Europe Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)

Figure 18.        Large Enterprises: Europe Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)

Figure 19.        Europe Manufacturing Execution System in Life Sciences Market Revenue Share, By Application (2022 and 2033)

Figure 20.        Pharmaceutical: Europe Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)

Figure 21.        Biotechnology: Europe Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)

Figure 22.        Medical Devices: Europe Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)

Figure 23.        Europe Manufacturing Execution System in Life Sciences Market, by Key Country – Revenue (2022) (US$ Million)

Figure 24.        Germany: Europe Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)

Figure 25.        France: Europe Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)

Figure 26.        Italy: Europe Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)

Figure 27.        UK: Europe Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)

Figure 28.        Spain: Europe Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)

Figure 29.        Rest of Europe: Europe Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)

 

  1. ATS Global B.V.
  2. Emerson Electric Co
  3. Korber AG
  4. LZ Lifescience Limited
  5. Rockwell Automation Inc
  6. Schneider Electric SE
  7. Siemens AG
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000